NASOPHARYNGEAL CANCER
Clinical trials for NASOPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug tested in advanced tumors – study halted early
Disease control TerminatedThis early-stage study tested an experimental drug called INCB062079 in 25 people with advanced liver cancer (hepatocellular carcinoma) and several other solid tumors. The main goal was to check the drug's safety and find the highest dose people could tolerate. The study was term…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Experimental cancer drug TAK-500 tested in 61 patients
Disease control TerminatedThis study tested a new drug called TAK-500, given alone or with another drug (pembrolizumab), in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The main goals were to check safety and see if the drug could shrink tumors. The study was stopped early…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 23, 2026 12:45 UTC